Laidlaw Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Laidlaw Wealth Management's LLY Position: Q1 2026 in Review
Laidlaw Wealth Management increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $99.4K and bringing the position to 946 shares worth $870K. The position accounts for 3.02% of the portfolio, ranked #9.
Laidlaw Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Laidlaw Wealth Management held 946 shares of Eli Lilly worth $870K as of Q1 2026.
- Laidlaw Wealth Management bought 98 Eli Lilly shares in Q1 2026, an estimated $99.4K.
- Eli Lilly made up 3.02% of Laidlaw Wealth Management's portfolio in Q1 2026, its #9 holding.
- Laidlaw Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Laidlaw Wealth Management's Eli Lilly position peaked at $1.62M in Q4 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Laidlaw Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.